Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Neuroimage. Clinical|September 8, 2019
A study of neural activity and functional connectivity within the olfactory brain network in Parkinson's diseaseCharalampos Georgiopoulos, Suzanne T Witt, Sven Haller, et al.Movement Disorders Clinical Practice|June 26, 2024
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa InfusionFilip Bergquist, Mats Ehrnebo, Dag Nyholm, et al.European Journal of Neurology|December 3, 2024
Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's diseaseMezin Öthman, Filip Bergquist, Per Odin, et al.Journal of Parkinson'S Disease|October 7, 2017
Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's DiseaseThomas Willows, Nil Dizdar, Dag Nyholm, et al.Journal of the Neurological Sciences|February 7, 2009
Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophyAxel Petzold, Edward J Thompson, Geoffrey Keir, et al.Neurology|June 15, 2022
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson DiseaseFilip Bergquist, Mats Ehrnebo, Dag Nyholm, et al.BMC Medical Genetics|March 14, 2018
S100B polymorphisms are associated with age of onset of Parkinson's diseaseCamilla Fardell, Anna Zettergren, Caroline Ran, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2007
Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled studyBjörn Holmberg, Jan-Ove Johansson, Werner Poewe, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 22, 2020
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease DementiaPer Svenningsson, Per Odin, Nil Dizdar, et al.Parkinsonism & Related Disorders|June 20, 2016
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costsSven E Pålhagen, Olof Sydow, Anders Johansson, et al.Pageof 4